Search Result for ""
Story

Advancing awareness of lobular breast cancer

UT Health San Antonio’s Mays Cancer Center is hosting a Grand Rounds Oct. 15 — Global Lobular Breast Cancer Awareness Day — to spotlight new approaches to diagnosis and treatment of invasive lobular carcinoma, a common but often overlooked form of breast cancer.

A Phase 2, Randomized, Multicenter, Open-Label Neoadjuvant Study Evaluating Zanidatamab in Combination with Chemotherapy in Participants with HER2-Positive Breast Cancer A Phase 2, Randomized, Multicenter, Open-Label Neoadjuvant Study Evaluating Zanidatamab in Combination with Chemotherapy in Participants with HER2-Positive Breast Cancer The purpose of this study is to see if zanidatamab is safe and effective, when combined with chemotherapy, in treating people who has Human Epidermal Growth Factor Receptor 2 (HER2)-positive, early-stage breast cancer.NCT07102381Saba Shaikh, MD